Met/HGF receptor activation is regulated by juxtamembrane Ser985 phosphorylation in hepatocytes

Cytokine

Volumn 62, Issue 3, 2013, Pages 446-452

  Nakayama, Mizuho ^a   Sakai, Katsuya ^a   Yamashita, Atsuko ^a   Nakamura, Takahiro ^a   Suzuki, Yoshinori ^a   Matsumoto, Kunio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Growth factor; Liver injury; Liver regeneration; Primary culture; Receptor tyrosine kinase

Indexed keywords

SCATTER FACTOR RECEPTOR; SERINE; MITOGENIC AGENT; PHOSPHOSERINE; SCATTER FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; IMMUNOPRECIPITATION; LIVER CELL; LIVER REGENERATION; MALE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; CELL FRACTIONATION; DRUG EFFECTS; FEMALE; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER; METABOLISM; MOUSE; PATHOLOGY; PHOSPHORYLATION; PROTEIN TRANSPORT; SPRAGUE DAWLEY RAT;

MUS;

ANIMALS; FEMALE; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMANS; LIVER; MICE; MICE, INBRED ICR; MITOGENS; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-MET; RATS; RATS, SPRAGUE-DAWLEY; SUBCELLULAR FRACTIONS;

EID: 84877795563     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.04.006     Document Type: Article

References (38)

1. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989, 342:440-443.
2. Miyazawa K., Tsubouchi H., Naka D., Takahashi K., Okigaki M., Arakaki N., et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989, 163:967-973.
3. Matsumoto K., Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996, 119:591-600.
4. Birchmeier C., Birchmeier W., Gherardi E., Vande Woude G.F. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003, 4:915-925.
5. Birchmeier C., Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 1998, 8:404-409.
6. Huh C.G., Factor V.M., Sanchez A., Uchida K., Conner E.A., Thorgeirsson S.S. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA 2004, 101:4477-4482.
7. Borowiak M., Garratt A.N., Wustefeld T., Strehle M., Trautwein C., Birchmeier C. Met provides essential signals for liver regeneration. Proc Natl Acad Sci USA 2004, 101:10608-10613.
8. Nakamura T., Sakai K., Nakamura T., Matsumoto K. Hepatocyte growth factor twenty years on: much more than a growth factor. J Gastroenterol Hepatol 2011, 26:188-202.
9. Comoglio P.M., Giordano S., Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 2008, 7:504-516.
10. Lee C.C., Yamada K.M. Identification of a novel type of alternative splicing of a tyrosine kinase receptor. J Biol Chem 1994, 269:19457-19461.
11. Gandino L., Longati P., Medico E., Prat M., Comoglio P.M. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase. J Biol Chem 1994, 69:1815-1820.
12. Weidner K.M., Sachs M., Riethmacher D., Birchmeier W. Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells. Proc Natl Acad Sci USA 1995, 92:2597-2601.
13. Peschard P., Fournier T.M., Lamorte L., Naujokas M.A., Band H., Langdon W.Y., et al. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol Cell 2001, 8:995-1004.
14. Hashigasako A., Machide M., Nakamura T., Matsumoto K., Nakamura T. Bi-directional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor. J Biol Chem 2004, 279:26445-26452.
15. Ishiki Y., Ohnishi H., Muto Y., Matsumoto K., Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992, 16:1227-1235.
16. Kosai K., Matsumoto K., Nagata S., Tsujimoto Y., Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 1998, 244:683-690.
17. Beguinot L., Hanover J.A., Ito S., Richert N.D., Willingham M.C., Pastan I. Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors. Proc Natl Acad Sci USA 1985, 82:2774-2778.
18. Bao J., Alroy I., Waterman H., Schejter E.D., Brodie C., Gruenberg J., et al. Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome. J Biol Chem 2000, 275:26178-26186.
19. Tong J., Taylor P., Peterman S.M., Prakash A., Moran M.F. Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041. Mol Cell Proteomics 2009, 8:2131-2144.
20. Schlegel R., Dickson R.B., Willingham M.C., Pastan I.H. Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of alpha 2-macroglobulin. Proc Natl Acad Sci USA 1982, 79:2291-2295.
21. Wang L.H., Rothberg K.G., Anderson R.G. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 1993, 123:1107-1117.
22. +-ATPase activity depends on membrane lipid fluidity. Proc Natl Acad Sci USA 1988, 85:8673-8677.
23. Le Roy C., Wrana J.L. Signaling and endocytosis: a team effort for cell migration. Dev Cell 2005, 9:167-168.
24. Polo S., Di Fiore P.P. Endocytosis conducts the cell signaling orchestra. Cell 2006, 124:897-900.
25. Joffre C., Barrow R., Ménard L., Calleja V., Hart I.R., Kermorgant S. A direct role for Met endocytosis in tumorigenesis. Nat Cell Biol 2011, 13:827-837.
26. Miyazawa K. Hepatocyte growth factor activator (HGFA): a serine protease that links tissue injury to activation of hepatocyte growth factor. FEBS J 2010, 277:2208-2214.
27. Kadoyama K., Funakoshi H., Ohya-Shimada W., Nakamura T., Matsumoto K., Matsuyama S., et al. Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS. Neurosci Res 2009, 65:194-200.
28. Hunter T., Ling N., Cooper J.A. Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature 1984, 311:480-483.
29. Thiel K.W., Carpenter G. Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation. Proc Natl Acad Sci USA 2007, 104:19238-19243.
30. Andreozzi F., Melillo R.M., Carlomagno F., Oriente F., Miele C., Fiory F., et al. Protein kinase Cδ activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase. Oncogene 2003, 22:2942-2949.
31. 2. Proc Natl Acad Sci USA 1997, 94:11233-11237.
32. Toker A. Signaling through protein kinase C. Front Biosci 1998, 3:D1134-D1147.
33. Churchill E.N., Mochly-Rosen D. The roles of PKCδ and ε isoenzymes in the regulation of myocardial ischaemia/reperfusion injury. Biochem Soc Trans 2007, 35:1040-1042.
34. Griner E.M., Kazanietz M.G. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 2007, 7:281-294.
35. Janssens V., Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 2001, 353:417-439.
36. Janssens V., Goris J., Van Hoof C. PP2A: the expected tumor suppressor. Curr Opin Genet Dev 2005, 15:34-41.
37. Rodrigues G.A., Park M. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol Cell Biol 1993, 13:6711-6722.
38. Vigna E., Gramaglia D., Longati P., Bardelli A., Comoglio P.M. Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET. Oncogene 1999, 18:4275-4281.